One-year morbidity after sentinel node biopsy and breast surgery.
Posttreatment morbidity within 1 year after sentinel node biopsy was evaluated objectively by physical examination and also by evaluating patients self-reports of symptoms in a questionnaire. These patients were compared with patients who underwent axillary clearance. At 2 weeks after surgery patients who had undergone sole sentinel node biopsy had made significantly better recoveries than those who had undergone axillary clearance. Although every fourth patient complained of at least mild arm symptoms 1 year after sole SNB, the risk of severe long-term morbidity is minimal. In particular, the risk of disabling lymphoedema seems to be negligible after SNB only.
Rönkä
R
R
Breast Surgery Unit, Helsinki University Hospital, Helsinki, Finland. riitta.ronka@hus.fi
von Smitten
K
K
Tasmuth
T
T
Leidenius
M
M
D000203:Activities of Daily Living; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001365:Axilla; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008197:Lymph Node Excision / Q000009:adverse effects*; D008875:Middle Aged; D009017:Morbidity; D011183:Postoperative Complications; D012307:Risk Factors; D021701:Sentinel Lymph Node Biopsy / Q000009:adverse effects*